Page last updated: 2024-08-16

moxonidine and propafenone

moxonidine has been researched along with propafenone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Bouras, G; Deftereos, S; Efremidis, M; Giannopoulos, G; Kaoukis, A; Karageorgiou, S; Katsivas, A; Kossyvakis, C; Panagopoulou, V; Pyrgakis, V; Raisakis, K; Stefanadis, C	1

Trials

1 trial(s) available for moxonidine and propafenone

Article	Year
Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients. The American journal of cardiology, 2013, Sep-01, Volume: 112, Issue:5 Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Propafenone; Sotalol; Sympatholytics; Treatment Outcome	2013

Article

Year

Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients.

The American journal of cardiology, 2013, Sep-01, Volume: 112, Issue:5

Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Propafenone; Sotalol; Sympatholytics; Treatment Outcome

2013

Other Studies

1 other study(ies) available for moxonidine and propafenone

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008